Company / Return on Equity (ROE)
FILANA THERAPEUTICS, INC. Return on Equity (ROE) History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
65.3%
FY2015
5-year range
-36.5% / 65.3%
FY2011-FY2015
Trend
+349.0%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) changed +349% YoY in FY2015, a notable deviation from the 4-year average annual change of -238%.
Based on SEC 10-K filings.
65.3% in FY2015 with a 3-year CAGR of +101.8%.
Improved from -5.9% to 65.3% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +101.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2015, return on equity (roe) increased 349.0% year-over-year.
- Lowest return on equity (roe) in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2015 | 65.3% | +349.0% |
| FY2014 | -26.2% | -345.3% |
| FY2013 | -5.9% | +83.9% |
| FY2012 | -36.5% | -1040.9% |
| FY2011 | -3.2% | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026